Huei-Ju Ting, Ph.D. - Publications

Affiliations: 
2002 University of Rochester, Rochester, NY 
Area:
Molecular Biology, Oncology

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Lin VC, Huang SP, Ting HJ, Ma WL, Yu CC, Huang CY, Yin HL, Huang TY, Lee CH, Chang TY, Lu TL, Bao BY. Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget. 8: 74119-74128. PMID 29088772 DOI: 10.18632/oncotarget.18271  0.72
2017 Hsu CL, Liu JS, Lin TW, Chang YH, Kuo YC, Lin AC, Ting HJ, Pang ST, Lee LY, Ma WL, Lin CC, Wu WG. Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening. Oncotarget. 8: 69508-69519. PMID 29050220 DOI: 10.18632/oncotarget.17843  0.76
2017 Lin VC, Huang SP, Ting HJ, Ma WL, Yu CC, Huang CY, Yin HL, Huang TY, Lee CH, Chang TY, Lu TL, Bao BY. Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget. PMID 28618396 DOI: 10.18632/oncotarget.18271  0.72
2017 Hsu CL, Liu JS, Lin TW, Chang YH, Kuo YC, Lin AC, Ting HJ, Pang ST, Lee LY, Ma WL, Lin CC, Wu WG. Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening. Oncotarget. PMID 28562322 DOI: 10.18632/oncotarget.17843  0.76
2014 Hsu CL, Liu JS, Wu PL, Guan HH, Chen YL, Lin AC, Ting HJ, Pang ST, Yeh SD, Ma WL, Chen CJ, Wu WG, Chang C. Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis. Molecular Oncology. 8: 1575-87. PMID 25091737 DOI: 10.1016/j.molonc.2014.06.009  0.64
2014 Beckham CJ, Olsen J, Yin PN, Wu CH, Ting HJ, Hagen FK, Scosyrev E, Messing EM, Lee YF. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. The Journal of Urology. 192: 583-92. PMID 24530986 DOI: 10.1016/j.juro.2014.02.035  0.72
2013 Ting HJ, Messing J, Yasmin-Karim S, Lee YF. Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D. The Journal of Biological Chemistry. 288: 1-9. PMID 23188821 DOI: 10.1074/jbc.M112.395947  0.72
2012 Yan SJ, Lee YF, Ting HJ, Liu NC, Liu S, Lin SJ, Yeh SD, Li G, Chang C. Deficiency in TR4 nuclear receptor abrogates Gadd45a expression and increases cytotoxicity induced by ionizing radiation. Cellular & Molecular Biology Letters. 17: 309-22. PMID 22396141 DOI: 10.2478/s11658-012-0012-9  0.64
2012 Ting HJ, Yasmin-Karim S, Yan SJ, Hsu JW, Lin TH, Zeng W, Messing J, Sheu TJ, Bao BY, Li WX, Messing E, Lee YF. A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D. Cancer Research. 72: 958-68. PMID 22207345 DOI: 10.1158/0008-5472.CAN-11-0042  0.64
2011 Collins LL, Lee YF, Ting HJ, Lin WJ, Liu NC, Meshul CK, Uno H, Bao BY, Chen YT, Chang C. The roles of testicular nuclear receptor 4 (TR4) in male fertility-priapism and sexual behavior defects in TR4 knockout mice. Reproductive Biology and Endocrinology : Rb&E. 9: 138. PMID 21995792 DOI: 10.1186/1477-7827-9-138  0.64
2011 Liu S, Yan SJ, Lee YF, Liu NC, Ting HJ, Li G, Wu Q, Chen LM, Chang C. Testicular nuclear receptor 4 (TR4) regulates UV light-induced responses via Cockayne syndrome B protein-mediated transcription-coupled DNA repair. The Journal of Biological Chemistry. 286: 38103-8. PMID 21918225 DOI: 10.1074/jbc.M111.259523  0.64
2011 Lee YF, Liu S, Liu NC, Wang RS, Chen LM, Lin WJ, Ting HJ, Ho HC, Li G, Puzas EJ, Wu Q, Chang C. Premature aging with impaired oxidative stress defense in mice lacking TR4. American Journal of Physiology. Endocrinology and Metabolism. 301: E91-8. PMID 21521714 DOI: 10.1152/ajpendo.00701.2010  0.64
2011 Hsu JW, Yasmin-Karim S, King MR, Wojciechowski JC, Mickelsen D, Blair ML, Ting HJ, Ma WL, Lee YF. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3. The American Journal of Pathology. 178: 872-80. PMID 21281819 DOI: 10.1016/j.ajpath.2010.10.036  0.64
2010 Bao BY, Ting HJ, Hsu JW, Yasmin-Karim S, Messing E, Lee YF. Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness. The Journal of Steroid Biochemistry and Molecular Biology. 120: 11-21. PMID 20206692 DOI: 10.1016/j.jsbmb.2010.02.030  0.72
2008 Ting HJ, Chang C. Actin associated proteins function as androgen receptor coregulators: an implication of androgen receptor's roles in skeletal muscle. The Journal of Steroid Biochemistry and Molecular Biology. 111: 157-63. PMID 18590822 DOI: 10.1016/j.jsbmb.2008.06.001  0.76
2008 Bao BY, Ting HJ, Hsu JW, Lee YF. Protective role of 1 alpha, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells. International Journal of Cancer. Journal International Du Cancer. 122: 2699-706. PMID 18348143 DOI: 10.1002/ijc.23460  0.72
2007 Ting HJ, Bao BY, Reeder JE, Messing EM, Lee YF. Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness. Molecular Cancer Research : McR. 5: 967-80. PMID 17855664 DOI: 10.1158/1541-7786.MCR-06-0318  0.72
2007 Ting HJ, Hsu J, Bao BY, Lee YF. Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha,25-dihydroxyvitamin D3. Cancer Letters. 247: 122-9. PMID 16644109 DOI: 10.1016/j.canlet.2006.03.025  0.72
2005 Ting HJ, Bao BY, Hsu CL, Lee YF. Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity. Endocrine. 26: 1-9. PMID 15805579 DOI: 10.1385/ENDO:26:1:001  0.76
2005 Hsu CL, Chen YL, Ting HJ, Lin WJ, Yang Z, Zhang Y, Wang L, Wu CT, Chang HC, Yeh S, Pimplikar SW, Chang C. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Molecular Endocrinology (Baltimore, Md.). 19: 350-61. PMID 15514032 DOI: 10.1210/me.2004-0190  0.76
2004 Altuwaijri S, Lee DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett LA, Chang HC, Chang C. Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types. Endocrine. 25: 27-32. PMID 15545703  0.76
2004 Ting HJ, Hu YC, Chang C. Actin monomer enhances supervillin-modulated androgen receptor transactivation. Biochemical and Biophysical Research Communications. 319: 393-6. PMID 15178419 DOI: 10.1016/j.bbrc.2004.04.186  0.76
2004 Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 279: 33438-46. PMID 15166229 DOI: 10.1074/jbc.M401781200  0.76
2004 Bao BY, Hu YC, Ting HJ, Lee YF. Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells. Oncogene. 23: 3350-60. PMID 15048085 DOI: 10.1038/sj.onc.1207461  0.76
2003 Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Research. 63: 4888-94. PMID 12941811  0.64
2003 Hsu CL, Chen YL, Yeh S, Ting HJ, Hu YC, Lin H, Wang X, Chang C. The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs. The Journal of Biological Chemistry. 278: 23691-8. PMID 12714604 DOI: 10.1074/jbc.M211908200  0.76
2002 Ting HJ, Yeh S, Nishimura K, Chang C. Supervillin associates with androgen receptor and modulates its transcriptional activity. Proceedings of the National Academy of Sciences of the United States of America. 99: 661-6. PMID 11792840 DOI: 10.1073/pnas.022469899  0.76
2001 Sampson ER, Yeh SY, Chang HC, Tsai MY, Wang X, Ting HJ, Chang C. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells. Journal of Biological Regulators and Homeostatic Agents. 15: 123-9. PMID 11501969  0.76
2000 Yeh S, Hu YC, Rahman M, Lin HK, Hsu CL, Ting HJ, Kang HY, Chang C. Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 97: 11256-61. PMID 11016951 DOI: 10.1073/pnas.190353897  0.76
1999 Yeh S, Kang HY, Miyamoto H, Nishimura K, Chang HC, Ting HJ, Rahman M, Lin HK, Fujimoto N, Hu YC, Mizokami A, Huang KE, Chang C. Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells. Endocrine. 11: 195-202. PMID 10709768  0.76
1999 Heinlein CA, Ting HJ, Yeh S, Chang C. Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma. The Journal of Biological Chemistry. 274: 16147-52. PMID 10347167  0.76
Show low-probability matches.